Хронический лимфолейкоз и рак почки: обзор литературы и собственные клинические наблюдения

КЛИНИКА, ДИАГНОСТИКА И ЛЕЧЕНИЕ ЛИМФОИДНЫХ ОПУХОЛЕЙ , , ,

Б.Т. Джумабаева, Е.А. Никитин, И.Б. Капланская, Е.Е. Зыбунова, Л.С. Бирюкова

ФГБУ «Гематологический научный центр МЗСР РФ», Москва, Российская Федерация

РЕФЕРАТ

Рак почки, развившийся у больных с хроническим лимфолейкозом в анамнезе или в дебюте заболевания может индуцировать прогрессию лимфоидной опухоли и способствовать быстрому развитию почечной недостаточности. Оперативное удаление пораженной раком почки не предотвращает прогрессию ХЛЛ. Монотерапия ХЛЛ алкилирующими препаратами не эффективна. Представлено наблюдение эффективного лечения ХЛЛ бендамустином.

Ключевые слова: хронический лимфолейкоз (ХЛЛ), почечная недостаточность, рак почки, бендамустин.

Читать статью  в PDFpdficon

ЛИТЕРАТУРА

  1. Manusow D., Weinerman B.H. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA 1975; 232: 267–9.
  2. Santoro A., Rilke F., Franchi F. et al. Primary malignant neoplasms associated with chronic lymphocytic leukemia. Tumori 1980; 66: 431–7.
  3. Mellemgaard A., Geisler C.H., Storm H.H. Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia. Eur. J. Haematol. 1994; 53: 218–27.
  4. Molica S., Alberti A. Second neoplasms in chronic lymphocytic leukemia: analysis of incidence as a function of the length of follow-up. Haematologica 1989; 74(5): 481–5.
  5. Kyasa M.J., Hazlett L., Parrish R.S., Schichman S.A., Zent C.S. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death. Leuk. Lymphoma 2004; 45: 507–13.
  6. Greene M.H., Hoover R.N., Fraumeni J.F. et al. Subsequent cancer in patients with chronic lymphocytic leukemia— a possible immunologic mechanism. J. Natl. Cancer Inst. 1978; 61: 337–40.
  7. Hisada M., Biggar R.J., Greene M.H. et al. Solid tumors after chronic lymphocytic leukemia. Blood 2001; 98: 1979–81.
  8. Mauro F.R., Foa R., Giannarelli D. et al. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood 1999; 94: 448–54.
  9. Suzuki K., Maekawa I., Mikuni C. et al. Prognosis in 75 cases of chronic lymphocytic leukemia and second malignancies. Rinsho Ketsueki. 1997; 38: 740–4.
  10. Parekh K., Rusch V., Kris M. The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia. Cancer 1999; 86: 1720–3.
  11. Pigeaud-Klessens M.L., van der Valk P. Multiple neoplasms: a case report. Orbit. 2002; 21: 145–8.
  12. Prosvic P., Dulicek P., Odrazka K. et al. Asynchronous occurrence of three neoplastic diseases: chronic B-cell lymphatic leukemia, renal carcinoma and prostatic adenocarcinoma. Chir. 2003; 82: 583–6.
  13. Тravis L.B., Curtis R.E., Boice J.D. et al. Second cancers following non-Hodgkin’s lymphoma. Cancer 1991; 67: 2002–9.
  14. Travis L.B., Curtis R.E., Glimelius B. et al. Second cancers among long-term survivors of non-Hodgkin’s lymphoma. J. Natl. Cancer Inst. 1993; 85: 1932–7.
  15. Anderson C.M., Puszatai L., Palmer J.L., Cabanillas F. Coincidental renal cell carcinoma and non-Hodgkin’s lymphoma: the M. D. Anderson experience and review of literature. J. Urol. 1998; 159: 714–6.
  16. Sendi P., Schonenberger A., Bargetzi M. Chronic lymphocytic leukemia and loss of strength in the right arm—not a typical combination. Praxis (Bern 1994). 2007; 96(18): 729–32.
  17. Kunthur A., Wiernik P.H., Dutcher J.P. Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature. Am. J. Hematol. 2006; 81(4): 271–80.
  18. Deeb R., Zhang Z., Ghanem T. Metastatic renal cell carcinoma to the parotid gland in the setting of chronic lymphocytic leukemia. Case Report Med. 2012 Feb 19.
  19. Sampalo A., Navas G., Medina F. et al. Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction. Blood 2000; 96: 3168–74.
  20. Orfao A., Gonzalez M., San Miguel J.F. et al. Surface phenotype and immunoglobulin levels in B-cell chronic lymphocytic leukaemia. Haematologia (Budap.) 1990; 23: 49–56.
  21. Varan A., Buyukpamukcu M., Ersov F. et al. Malignant solid tumors associated with congenital immunodeficiency disorders. Pediatr. Hematol. Oncol. 2004; 21: 441–51.
  22. Perri R.T., Kay N.E. Abnormal T cell function in early-stage chronic lymphocytic leukemia (CLL) patients. Am. J. Hematol. 1986; 22: 55–61.
  23. Piszcz J., Oleksiuk J., Kloczko J. Gastric cancer in chronic lymphocytic leukaemia patient. Pol. Arch. Med. Wewn. 2005; 114: 1217–9.
  24. Hsu C.W., Krevsky B., Sigman L.M. et al. Rapid progression of Barrett’s esophagus to metastatic esophageal carcinoma in a patient with chronic lymphocytic leukemia. J. Clin. Gastroenterol. 1998; 27: 261–4.
  25. Brown J.R., Freedman A.S. Secondary solid tumors after autologous bone marrow transplantation in non-Hodgkin’s lymphoma. Am. J. Oncol. Rev. 2005; 4: 530–3.
  26. Morra E., Nosari A., Montillo M. Infectious complications in chronic lymphocytic leukaemia. Hematol. Cell Ther. 1999; 41: 145–51.
  27. Cheson B.D., Vena D.A., Barrett J. et al. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. J. Clin. Oncol. 1999; 17: 2454–60.
  28. Robak T. Monoclonal antibodies in the treatment of chronic lymphoid leukemias. Lymphoma 2004; 45: 205–19.
  29. Callea V., Brugiatelli M., Stelitano C. et al. Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy. Lymphoma. 2006; 47: 2314–20.
  30. Van , Laneuville P., MacDonald D. et al. A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma. Curr. Oncol. 2012; 19(3): 160–8.